Literature DB >> 6796750

Catecholamines, renin, aldosterone, and blood volume during chronic minoxidil therapy.

A Meier, P Weidmann, W H Ziegler.   

Abstract

Several pressor factors were studied before and during chronic minoxidil therapy (median dose 27.5 mg/day) in 16 patients with hypertension that was refractory to conventional drugs. Following treatment with minoxidil and intensified diuretic therapy, blood pressure was decreased markedly; pulse rate, body weight, plasma volume, plasma aldosterone and epinephrine levels were not significantly altered, while plasma renin activity tended to be increased. Supine and upright plasma norepinephrine concentrations were increased by 140 (P less than 0.005) and 50% (P less than 0.05), respectively, but no significant change in urinary norepinephrine excretion was apparent. The latter parameter may not be a close index of sympathetic activity in patients with severe hypertension treated with minoxidil. While a search for underlying pheochromocytoma is always indicated in refractory hypertension, it appears mandatory to evaluate plasma catecholamines prior to or following discontinuation of treatment with minoxidil, to avoid a wrong diagnosis of pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796750     DOI: 10.1007/BF01747754

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  25 in total

1.  Responsiveness of plasma aldosterone: dependency upon basal secretory activity.

Authors:  F H Messerli; P Weidmann; R DeChâtel; M H Maxwell
Journal:  Klin Wochenschr       Date:  1978-07-15

Review 2.  Minoxidil therapy in refractory hypertension analysis of 155 patients.

Authors:  G W Keusch; P Weidmann; V Campese; D B Lee; A T Upham; S G Massry
Journal:  Nephron       Date:  1978       Impact factor: 2.847

Review 3.  Vasodilator drugs in the treatment of hypertension.

Authors:  J Koch-Weser
Journal:  Arch Intern Med       Date:  1974-06

4.  Rapid blood pressure control with minoxidil: acute and chronic effects on blood pressure, sodium excretion, and the renin-aldosterone system.

Authors:  C E Grim; F C Luft; C M Grim; P E Klotman; J W Van Huysse; M H Weinberger
Journal:  Arch Intern Med       Date:  1979-05

5.  Minoxidil--an alternative to nephrectomy for refractory hypertension.

Authors:  W A Pettinger; H C Mitchell
Journal:  N Engl J Med       Date:  1973-07-26       Impact factor: 91.245

6.  Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.

Authors:  W Vetter; H Vetter; W Siegenthaler
Journal:  Acta Endocrinol (Copenh)       Date:  1973-11

7.  Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension.

Authors:  P Weidmann; C Beretta-Piccoli; W H Ziegler; G Keusch; Z Glück; F C Reubi
Journal:  Kidney Int       Date:  1978-12       Impact factor: 10.612

8.  Effect of minoxidil on blood pressure and hemodynamics in severe hypertension.

Authors:  R K Bryan; S W Hoobler; J Rosenzweig; J M Weller; J M Purdy
Journal:  Am J Cardiol       Date:  1977-05-26       Impact factor: 2.778

9.  Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension.

Authors:  P Weidmann; D Hirsch; C Beretta-Piccoli; F C Reubi; W H Ziegler
Journal:  Am J Med       Date:  1977-02       Impact factor: 4.965

10.  Long-term treatment of refractory hypertensive patients with minoxidil.

Authors:  H C Mitchell; W A Pettinger
Journal:  JAMA       Date:  1978-05-19       Impact factor: 56.272

View more
  4 in total

1.  Minoxidil and captopril in severe hypertension.

Authors:  P Greminger; E Foerster; H Vetter; P Baumgart; W Vetter
Journal:  Klin Wochenschr       Date:  1986-04-01

2.  Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.

Authors:  M G Bianchetti; P Weidmann; K Boehringer; L Link; H Schiffl; C Beretta-Piccoli; J P Colombo
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Direct vasodilators and their role in hypertension management: minoxidil.

Authors:  D A Sica; T W Gehr
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Mar-Apr       Impact factor: 3.738

Review 4.  Minoxidil: an underused vasodilator for resistant or severe hypertension.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-05       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.